ENALAPRIL/DITIAZEM ER SEVERE HYPERTENSION STUDY

依那普利/地硫卓严重高血压研究

• 批准号: 3743961
• 负责人: EDWARD C. CONRADI
• 金额: --
• 依托单位: MEDICAL UNIVERSITY OF SOUTH CAROLINA
• 依托单位国家: 美国
• 资助国家: 美国
• 起止时间: 至
• 项目状态: 未结题
• 来源: https://reporter.nih.gov/project-details/3743961
• 关键词: antihypertensive agents; cardiovascular disorder chemotherapy; clinical trials; combination chemotherapy; drug screening /evaluation; enalapril; human subject; human therapy evaluation; hypertension

This open-label, multi-center trial will investigate the hypothesis that enalapril (5 mg) combined with ditiazem ER (120 mg or 180 mg) is safe, well-tolerated, and effective in lowering blood pressure as combination therapy alone or with other antihypertensive therapies in patients with severe hypertension.

这项开放标签、多中心试验将研究以下假设： 依那普利（5 mg）联合地硫卓缓释片（120 mg或180 mg）是安全的， 耐受性良好，联合用药可有效降低血压 单药治疗或与其他抗高血压治疗联合治疗 严重高血压。